Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients (English)
- New search for: Asano, Arisa
- New search for: Ri, Masaki
- New search for: Masaki, Ayako
- New search for: Maeda, Yasuhiro
- New search for: Tachita, Takuto
- New search for: Hirade, Kentaro
- New search for: Marumo, Yoshiaki
- New search for: Nakashima, Takahiro
- New search for: Hagiwara, Shinya
- New search for: Kinoshita, Shiori
- New search for: Suzuki, Tomotaka
- New search for: Narita, Tomoko
- New search for: Kusumoto, Shigeru
- New search for: Komatsu, Hirokazu
- New search for: Inagaki, Hiroshi
- New search for: Iida, Shinsuke
- New search for: Asano, Arisa
- New search for: Ri, Masaki
- New search for: Masaki, Ayako
- New search for: Maeda, Yasuhiro
- New search for: Tachita, Takuto
- New search for: Hirade, Kentaro
- New search for: Marumo, Yoshiaki
- New search for: Nakashima, Takahiro
- New search for: Hagiwara, Shinya
- New search for: Kinoshita, Shiori
- New search for: Suzuki, Tomotaka
- New search for: Narita, Tomoko
- New search for: Kusumoto, Shigeru
- New search for: Komatsu, Hirokazu
- New search for: Inagaki, Hiroshi
- New search for: Iida, Shinsuke
In:
Hematological Oncology
;
41
, 3
;
424-433
;
2023
- Article (Journal) / Electronic Resource
-
Title:Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients
-
Contributors:Asano, Arisa ( author ) / Ri, Masaki ( author ) / Masaki, Ayako ( author ) / Maeda, Yasuhiro ( author ) / Tachita, Takuto ( author ) / Hirade, Kentaro ( author ) / Marumo, Yoshiaki ( author ) / Nakashima, Takahiro ( author ) / Hagiwara, Shinya ( author ) / Kinoshita, Shiori ( author )
-
Published in:Hematological Oncology ; 41, 3 ; 424-433
-
Publisher:
-
Publication date:2023-08-01
-
Size:10 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 41, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 291
-
Issue Information| 2023
- 293
-
Richter transformation in Chronic Lymphocytic LeukemiaInnocenti, Idanna / Benintende, Giulia / Tomasso, Annamaria / Fresa, Alberto / Autore, Francesco / Larocca, Luigi Maria / Laurenti, Luca et al. | 2023
- 301
-
Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancyCao, Han‐Yu / Li, Ling / Xue, Sheng‐Li / Dai, Hai‐Ping et al. | 2023
- 310
-
TAFRO syndrome: A disease that known is half curedChen, Tingting / Feng, Chun / Zhang, Xinyou / Zhou, Jihao et al. | 2023
- 323
-
The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myelomaEseonu, Kelechi C. / Panchmatia, Jaykar R. / Streetly, Matthew J. / Grauer, Jonathan N. / Fakouri, Bahram et al. | 2023
- 335
-
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patientsDerenzini, Enrico / Gueli, Angela / Risso, Alessandra / Bruna, Riccardo / Gottardi, Daniela / Cignetti, Alessandro / Pileri, Stefano / Avvedimento, Enrico V. / Tarella, Corrado et al. | 2023
- 343
-
Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective studyAssanto, Giovanni Manfredi / Di Rocco, Alice / Malfona, Francesco / Capriata, Marcello / Del Giudice, Ilaria / Petrucci, Luigi / Girardi, Paola / D’Elia, Gianna Maria / Martelli, Maurizio / Gentile, Giuseppe et al. | 2023
- 354
-
Risk of a second cancer and infection in patients with indolent B‐cell lymphoma exposed to first‐line bendamustine plus rituximab: A retrospective analysis of an administrative claims databaseDote, Satoshi / Inose, Ryo / Goto, Ryota / Kobayashi, Yuka / Muraki, Yuichi et al. | 2023
- 363
-
Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective studyMattiello, Veronica / Barone, Angelica / Giannarelli, Diana / Noto, Alessandro / Cecchi, Nicola / Rampi, Nicolò / Cassin, Ramona / Reda, Gianluigi et al. | 2023
- 371
-
Malnutrition diagnosed by GLIM criteria better predicts long‐term outcomes for patients with non‐Hodgkin's lymphoma: A prospective multicenter cohort studyZou, Yuanlin / Xu, Hongxia / Lyu, Quanjun / Weng, Min / Cui, Jiuwei / Shi, Hanping / Song, Chunhua et al. | 2023
- 380
-
Prognostic value of prognostic nutritional index on extranodal natural killer/T‐cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working GroupShen, Ziyuan / Zhang, Shuo / Chen, Xicheng / Zhang, Qing / Jiao, Yaxue / Shi, Yuye / Zhang, Hao / Ye, Jingjing / Wang, Ling / Zhu, Taigang et al. | 2023
- 389
-
Lenalidomide treatment for recurrent adult T‐cell leukemia/lymphoma after allogeneic hematopoietic cell transplantationTanaka, Takashi / Inamoto, Yoshihiro / Ito, Ayumu / Watanabe, Mizuki / Takeda, Wataru / Aoki, Jun / Kim, Sung‐Won / Fukuda, Takahiro et al. | 2023
- 396
-
Efficacy and safety of PD‐1 inhibitor alone or combined with chemotherapy in patients with relapsed or refractory extranodal natural Killer/T cell lymphoma: A retrospective studyTian, Jing / Hao, Miaowang / Liu, Qiang / Xiao, Fang / Li, Yuanchun / Qi, Meiying / Gao, Jing / Liu, Li / Yin, Dandan et al. | 2023
- 407
-
Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general populationNúñez‐García, Beatriz / Clemente, Mariola Blanco / Sánchez, Juan Cristóbal / Royuela, Ana / Ibargüen, Blanca Cantos Sánchez de / Méndez, Miriam / López‐Ibor, Jorge V. / Martínez, Marta / Traseira, Cristina / Garitaonaindia, Yago et al. | 2023
- 415
-
Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trialBiggi, Alberto / Chauvie, Stephane / Fallanca, Federico / Guerra, Luca / Bergesio, Fabrizio / Menga, Massimo / Bianchi, Andrea / Gregianin, Michele / Chiaravalloti, Agostino / Schillaci, Orazio et al. | 2023
- 424
-
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patientsAsano, Arisa / Ri, Masaki / Masaki, Ayako / Maeda, Yasuhiro / Tachita, Takuto / Hirade, Kentaro / Marumo, Yoshiaki / Nakashima, Takahiro / Hagiwara, Shinya / Kinoshita, Shiori et al. | 2023
- 434
-
Diagnostic relevance of 2‐[18F]‐FDG PET/CT in patients recently diagnosed with monoclonal gammopathy of undetermined significanceRudolphi‐Solero, Teodoro / Triviño‐Ibáñez, Eva María / González‐Jiménez, Antonio Daniel / Ramos‐Font, Carlos / Ríos‐Tamayo, Rafael / Rebollo‐Aguirre, Angel Custodio / Sánchez‐Sánchez, Rocío et al. | 2023
- 442
-
Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs studySunami, Kazutaka / Fuchida, Shin‐ichi / Suzuki, Kenshi / Ri, Masaki / Matsumoto, Morio / Shimazaki, Chihiro / Asaoku, Hideki / Shibayama, Hirohiko / Ishizawa, Kenichi / Takamatsu, Hiroyuki et al. | 2023
- 453
-
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myelomaKauer, Joseph / Sester, Lilli Sophie / Kriegsmann, Katharina / Weinhold, Niels / Ober, Michael / Müller‐Tidow, Carsten / Goldschmidt, Hartmut / Raab, Marc‐Steffen / Sauer, Sandra et al. | 2023
- 463
-
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromesLee, Wan‐Hsuan / Lin, Chien‐Chin / Wang, Yu‐Hung / Yao, Chi‐Yuan / Kuo, Yuan‐Yeh / Tseng, Mei‐Hsuan / Peng, Yen‐Ling / Hsu, Cheng‐An / Sun, Hsun‐I / Chuang, Yi‐Kuang et al. | 2023
- 474
-
Heat shock protein 90 inhibitors induce cell differentiation via the ubiquitin‐dependent aurora kinase A degradation in a MPLW515L mouse model of primary myelofibrosisWang, Fuping / Zhang, Haotian / He, Binghong / Liu, Zihan / Wu, Xinxin / Liu, Yuankai / Xu, Xin / Gou, Xiaoxue / Wang, Haitao / Yang, Qiong et al. | 2023
- 487
-
Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemiaSamara, Aladin / Anbar, Michael / Shapira, Saar / Zemlyansky, Anna / Zozovsky, Alla / Raanani, Pia / Granot, Galit / Rozovski, Uri et al. | 2023
- 499
-
Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approachCheng, Po‐Liang / Hsiao, Tzu‐Hung / Chen, Chung‐Hsing / Hung, Miao‐Neng / Jhan, Pei‐Pei / Lee, Li‐Wen / Wu, Ting‐Shuan / Tsai, Jia‐Rung / Teng, Chieh‐Lin Jerry et al. | 2023
- 510
-
Knockdown of let‐7b in leukemia associated macrophages inhibit acute myeloid leukemia progressionTian, Chen / Li, Yueyang / Si, Junqi / Kang, Junnan / Chen, Zehui / Nuermaimaiti, Rexidan / Wang, Yafei / Yu, Yong / Zhao, Zhigang / Wang, Xiaofang et al. | 2023
- 520
-
Capitalizing on paradoxical activation of the mitogen‐activated protein kinase pathway for treatment of Imatinib‐resistant mast cell leukemiaWilhelm, Thomas / Toledo, Marcelo A. S. / Simons, Ilka / Stuth, Christian / Mohta, Vrinda / Mülfarth, Ronja / Nitsche, Marcus / Maschke‐Neuß, Karin / Schmitz, Susanne / Kaiser, Anne et al. | 2023
- 535
-
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working groupYanagisawa, Ryu / Tamaki, Masaharu / Tanoshima, Reo / Misaki, Yukiko / Uchida, Naoyuki / Koi, Satoshi / Tanaka, Takashi / Ozawa, Yukiyasu / Matsuo, Yayoi / Tanaka, Masatsugu et al. | 2023
- 546
-
15‐days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high‐risk myelodysplastic syndromes: A retrospective single‐center studyMei, Chen / Ye, Li / Ren, Yanling / Zhou, Xinping / Ma, Liya / Xu, Gaixiang / Xu, Weilai / Lu, Chenxi / Yang, Haiyang / Luo, Yingwan et al. | 2023
- 555
-
COVID‐19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationMasina, Lorenzo / Bianchetti, Nicola / Passi, Angela / Bottelli, Chiara / Bagnasco, Samuele / Spolzino, Angelica / Oberti, Margherita / Chiarini, Marco / Belotti, Angelo / Voltolini, Simone et al. | 2023
- 559
-
COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patientsDel Poeta, Giovanni / Laureana, Roberta / Bomben, Riccardo / Rossi, Francesca Maria / Pozzo, Federico / Zaina, Eva / Cattarossi, Ilaria / Varaschin, Paola / Nanni, Paola / Boschian Boschin, Romina et al. | 2023
- 563
-
Safety and efficacy of SARS‐Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR‐T cell infusionMetafuni, Elisabetta / Cingolani, Antonella / Fantoni, Massimo / Chiusolo, Patrizia / Giammarco, Sabrina / Sorà, Federica / Galli, Eugenio / Hohaus, Stefan / D’Alò, Francesco / Bellesi, Silvia et al. | 2023
- 567
-
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemiaMoia, Riccardo / Dondolin, Riccardo / De Propris, Maria Stefania / Talotta, Donatella / Mouhssine, Samir / Perutelli, Francesca / Reda, Gianluigi / Mattiello, Veronica / Rigolin, Gian Matteo / Motta, Marina et al. | 2023
- 571
-
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomasAutore, Francesco / Fresa, Alberto / Innocenti, Idanna / Principe, Maria Ilaria Del / Maglione, Raffaele / Stefanizzi, Caterina / Pelliccia, Sabrina / Romeo, Azzurra / Cimino, Giuseppe / Papa, Elena et al. | 2023
- 574
-
Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM studyVarettoni, Marzia / Zibellini, Silvia / Merli, Michele / Drandi, Daniela / Jiménez, Cristina / Furlan, Daniela / Ferretti, Virginia Valeria / Fabbri, Nicole / Dogliotti, Irene / Varraso, Chiara et al. | 2023
- 578
-
The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myelomaXu, Ning / Yu, Erin / Ng, Nicole / Li, Mingjie / Bujarski, Sean / Hekmati, Ava / Nassir, Isabella / Hekmati, Tara / Yu, Janna / Daniely, David et al. | 2023
- 583
-
Long‐term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patientsMaechler, Melanie / Bacher, Ulrike / Daskalakis, Michael / Nilius, Henning / Nagler, Michael / Taleghani, Behrouz Mansouri / Jeker, Barbara / Pabst, Thomas et al. | 2023
- 587
-
The impact of CD56 expression in smoldering myeloma patients on early progressionNotarfranchi, Laura / Segreto, Roberta / Vescovini, Rosanna / Dalla Palma, Anna Benedetta / Marchica, Valentina / Burroughs‐Garcia, Jessica / Toscani, Denise / Todaro, Giannalisa / Raimondi, Vincenzo / Iannozzi, Nicolas Thomas et al. | 2023
- 590
-
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105Suzuki, Tomotaka / Maruyama, Dai / Machida, Ryunosuke / Kataoka, Tomoko / Fukushima, Noriyasu / Takayama, Nobuyuki / Ohba, Rie / Omachi, Ken / Imaizumi, Yoshitaka / Tokunaga, Masahito et al. | 2023
- 594
-
Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with MEF2D fusionsSun, Kai / Chen, Wen‐Min / Wang, Xu / Zhao, Xiao‐Su / Li, Ling‐Di / Hao, Yue / Wang, Jun / Xu, Nan / Jiang, Qian / Jiang, Hao et al. | 2023
- 598
-
Distinguishing myelodysplastic syndromes with moderate‐to‐severe bone marrow fibrosis from triple‐negative primary myelofibrosis based on clinical and genetic covariatesWu, Junying / Zhang, Wenjun / Zhang, Peihong / Qin, Tiejun / Xu, Zefeng / Sun, Qi / Jia, Yujiao / Qu, Shiqiang / Li, Bing / Wang, Huijun et al. | 2023